Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 54 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Atezolizumab in addition to paclitaxel for inoperable, locally advanced or metastatic triple negative breast cancer – first-line	Atezolizumab (Tecentriq; MPDL3280A) , Paclitaxel (Taxol; paclitaxel albumin)	Breast cancer	Breast Cancer	2019	View \| Download
Alpelisib in Combination with Fulvestrant for Advanced HR Positive, HER2-negative Breast Cancer in Men and Postmenopausal Women	Alpelisib (BYL719; Piqray) , Fulvestrant (Faslodex)	Breast cancer	Breast Cancer	2017	View \| Download
Abemaciclib in combination with fulvestrant for advanced or metastatic breast cancer after prior endocrine therapy	Abemaciclib (LY2835219; Verzenio; CC-115) , Fulvestrant (Faslodex)	Breast cancer	Breast Cancer	2017	View \| Download
Abemaciclib for early breast cancer – adjuvant treatment	Abemaciclib (LY2835219; Verzenio; CC-115)	Breast cancer	Breast Cancer	2020	View \| Download